Tuesday, July 2, 2019

On the Record


"Educated employers are clearly defining brand, generic and single source drugs in their contract to prevent the PBM from satisfying their own needs, i.e., freely moving drugs from one category to the other to increase profits and/or meet contract guarantees."
— Cheryl Larson, vice president of the Midwest Business Group on Health (MBGH), spoke with AIS's RADAR on Drug Benefits about how employers can strategize with PBMs to reach agreements on drug pricing transparency. 

No comments:

Post a Comment